R. Machado

发表

UV-C (254 nm) lethal doses for SARS-CoV-2

M. Ribeiro, L. Freitas-Junior, E. Durigon, 2020, Photodiagnosis and Photodynamic Therapy.

Immunization with SARS-CoV-2 Nucleocapsid protein triggers a pulmonary immune response in rats

I. L. Noronha, S. Catanozi, E. Durigon, 2021, bioRxiv.

Nebulized enriched heparin to treat no critical patients with Sars-Cov-2

C. M. Fortaleza, H. Nader, F. F. Cardoso, 2021, Medicine.

Immunodominant B cell epitope in a hotspot mutation site and mechanism of immune escape for SARS-CoV-2

H. Nakaya, D. Schechtman, H. Arcuri, 2021 .

Immunodominant B cell epitope in SARS-CoV-2 RBD comprises a B.1.351 and P.1 mutation hotspot: implications for viral spread and antibody escape

H. Nakaya, G. Schmitz, D. Schechtman, 2021, medRxiv.

Multisystem Inflammatory Syndrome Associated With COVID-19 With Neurologic Manifestations in a Child: A Brief Report

F. Leal, R. Vieira, A. Bachi, 2020, The Pediatric infectious disease journal.

Impact of Convalescent Plasma Transfusion (CCP) In Patients With Previous Circulating Neutralizing Antibodies (nAb) to COVID-19

A. Marra, D. Araujo, N. Hamerschlak, 2020, medRxiv.

Validation of Serological Methods for COVID-19 and Retrospective Screening of Health Employees and Visitors to the São Paulo University Hospital, Brazil

C. Soares, Robert Andreata-Santos, L. Ferreira, 2022, Frontiers in Cellular and Infection Microbiology.

Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial

M. Falavigna, T. Lisboa, R. Rosa, 2021, European Respiratory Journal.

Lower cost alternatives for molecular diagnosis of COVID-19: conventional RT-PCR and SYBR Green-based RT-qPCR

F. Leal, V. Botosso, C. Soares, 2020, Brazilian Journal of Microbiology.

Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease

H. Chapman, M. Perbandt, C. Betzel, 2022, Communications Biology.

Zika Virus in Peridomestic Neotropical Primates, Northeast Brazil

P. Zanotto, F. Leal, Danielle B L Oliveira, 2019, EcoHealth.

Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape

H. Nakaya, D. Schechtman, H. Arcuri, 2023, Frontiers in Immunology.

A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: Proposals for better quality of CCP collections

D. Araujo, E. Durigon, S. Wendel, 2021, Transfusion.

Correlation of Body Mass Index (BMI), initial neutralizing antibodies (nAb), ABO group and kinetics of nAb and anti-nucleocapsid (NP) SARS-CoV-2 antibodies in convalescent plasma (CCP) donors: A longitudinal study with proposals for better quality of CCP collections.

D. Araujo, E. Durigon, S. Wendel, 2020, medRxiv.

Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program

C. Soares, D. Araujo, N. Hamerschlak, 2020, Transfusion.

Inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 Replication by Hypertonic Saline Solution in Lung and Kidney Epithelial Cells

H. Ulrich, Danielle B L Oliveira, D. Araujo, 2021, ACS pharmacology & translational science.

Hypertonic saline solution inhibits SARS-CoV-2 in vitro assay

H. Ulrich, Danielle B L Oliveira, D. Araujo, 2020, bioRxiv.

Alphacoronavirus Detection in Lungs, Liver, and Intestines of Bats from Brazil

E. Morielle-Versute, M. Nogueira, P. Rahal, 2019, Microbial Ecology.

Surrogate test performance for SARS‐CoV‐2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): How useful could they be?

C. Soares, E. Durigon, S. Wendel, 2021, Transfusion.

Lack of serological and molecular evidence of arbovirus infections in bats from Brazil

E. Morielle-Versute, M. Nogueira, P. Rahal, 2018, PloS one.

Identification of Zika Virus NS1-Derived Peptides with Potential Applications in Serological Tests

Robert Andreata-Santos, Luís Carlos de Souza Ferreira, L. Rocha, 2023, Viruses.

Preservation of SARS-CoV-2 Neutralizing Antibodies (nAb) or Anti-Nucleocapsid Proteins (NP) in Convalescent Donor Plasma (CCP) Treated with Amotosalen/UVA Illumination (A/UVA)

C. Soares, D. Araujo, E. Durigon, 2020 .

Ag nanoparticles-based antimicrobial polycotton fabrics to prevent the transmission and spread of SARS-CoV-2

E. Longo, J. Andrés, M. Assis, 2020, bioRxiv.

Beneficial effects of a mouthwash containing an antiviral phthalocyanine derivative on the length of hospital stay for COVID-19: randomised trial

D. Araujo, S. Toma, K. Araki, 2021, Scientific Reports.

SARS-CoV-2 isolation from the first reported patients in Brazil and establishment of a coordinated task network

V. Botosso, C. Soares, D. Araujo, 2020, Memorias do Instituto Oswaldo Cruz.

Anti‐A and SARS‐CoV‐2: an intriguing association

C. Soares, D. Araujo, J. Pinho, 2021, Vox sanguinis.

SARS-CoV-2 activates ER stress and Unfolded protein response

C. Wrenger, Danielle B L Oliveira, D. Araujo, 2021, bioRxiv.

Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing

D. Araujo, E. Sabino, C. de Almeida Neto, 2020, medRxiv.

COVID‐19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes

A. Marra, D. Araujo, J. Pinho, 2021, Transfusion.

Case Report: A Severe SARS-CoV-2 Infection in a Teenager With Angelman Syndrome

N. Câmara, Danielle B L Oliveira, M. Hiyane, 2021, Frontiers in Medicine.

Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI)

S. Chevret, R. Calado, V. Rocha, 2022, The Lancet Regional Health - Americas.

Neutralizing antibody response after immunization with a COVID-19 bivalent vaccine: Insights to the future.

Robert Andreata-Santos, J. H. Amorim, W. B. Luiz, 2024, Journal of Medical Virology.

Zika virus infection impairs synaptogenesis, induces neuroinflammation, and could be an environmental risk factor for autism spectrum disorder outcome.

I. Assunção-Miranda, J. Clarke, F. B. Russo, 2024, Biochimica et biophysica acta. Molecular basis of disease.